• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by VSee Health Inc.

    10/1/25 5:26:12 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care
    Get the next $VSEE alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    VSEE Health, Inc.

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    92919Y102

    (CUSIP Number)


    10/01/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Dominion Capital LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CONNECTICUT
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this statement on Schedule 13G (this ''Schedule 13G''), the percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share, of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount (defined below in this comment), (x) the shares of Common Stock issuable upon conversion of certain convertible promissory notes of the issuer directly and indirectly held by the Reporting Person (collectively the "Convertible Notes"), (y) the shares of Common Stock issuable upon the exercise of certain common stock purchase warrants of the issuer directly and indirectly held by the Reporting Person (collectively, the "Warrants") and (z) certain shares of Common Stock held directly and indirectly by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of Convertible Notes and Warrants, respectively, are all subject to 9.99% beneficial ownership limitation provisions contained therein (the "Blocker Amount"). (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Amendment No. 1 to Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission on August 29, 2025 (the "Annual Report"), plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, respectively, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Dominion Capital GP LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of the Convertible Notes, (y) the exercise of the Warrants and (z) certain shares of Common Stock held indirectly by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of Convertible Notes and Warrants, respectively, are all subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Dominion Capital Holdings LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of the Convertible Notes, (y) the exercise of the Warrants and (z) certain shares of Common Stock indirectly held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of Convertible Notes and Warrants, respectively, are all subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Ascent Partners Fund LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of a Convertible Note issued to the Reporting Person, (y) the exercise of a Warrant issued to the Reporting Person and (z) certain shares of Common Stock held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of such Convertible Note and Warrant, respectively, are subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Ascent Partners LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of a Convertible Note indirectly held by the Reporting Person, (y) the exercise of a Warrant indirectly held by the Reporting Person and (z) certain shares of Common Stock indirectly held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of such Convertible Note and Warrant, respectively, are subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Masada Group Holdings LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    FLORIDA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of a Convertible Note indirectly held by the Reporting Person, (y) the exercise of a Warrant indirectly held by the Reporting Person and (z) certain shares of Common Stock indirectly held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of such Convertible Note and Warrants, respectively, are all subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Mikhail Gurevich
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    HC, IN

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of the Convertible Notes indirectly held by the Reporting Person, (y) the exercise of the Warrants indirectly held by the Reporting Person and (z) certain shares of Common indirectly held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of the Convertible Notes and Warrants, respectively, are subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Gennadiy Gurevich
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    HC, IN

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, (x) the conversion of the Convertible Notes indirectly held by the Reporting Person, (y) the exercise of the Warrants indirectly held by the Reporting Person and (z) certain shares of Common Stock indirectly held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of the Convertible Notes and Warrants, respectively, are all subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    CUSIP No.
    92919Y102


    1Names of Reporting Persons

    Alon Brenner
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,816,389.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,816,389.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,816,389.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.9 %
    12Type of Reporting Person (See Instructions)

    HC, IN

    Comment for Type of Reporting Person:  (1) As more fully described in Item 4 of this Schedule 13G, the percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (5), (7) and (9) above includes, up to the Blocker Amount, (x) the conversion of a Convertible Note indirectly held by the Reporting Person, (y) the exercise of a Warrant indirectly held by the Reporting Person and (z) and certain shares of Common Stock indirectly held by the Reporting Person. The number of shares of Common Stock issuable upon conversion or exercise of such Convertible Note and Warrants are all subject to the Blocker Amount. (2) In Row (11) the percentage is based on (i) 16,422,690 shares of Common Stock outstanding as of August 27, 2025, as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding, and (ii) shares of Common Stock issuable upon conversion of the Convertible Notes and the exercise of the Warrants, subject to the Blocker Amount.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    VSEE Health, Inc.
    (b)Address of issuer's principal executive offices:

    980 N Federal Hwy #304, Boca Raton, Florida 33432.
    Item 2. 
    (a)Name of person filing:

    (i) Dominion Capital LLC, a Connecticut limited liability company ("Dominion"); (ii) Dominion Capital GP LLC, a Delaware limited liability company ("Dominion GP"); (iii) Dominion Capital Holdings LLC, a Delaware limited liability company ("Dominion Holdings"); (iv) Ascent Partners Fund LLC, a Delaware limited liability company ("Ascent"); (v) Ascent Partners LLC, a Delaware limited liability company ("AP"); (vi) Masada Group Holdings LLC, a Florida limited liability company ("Masada"); (vii) Mikhail Gurevich; (viii) Gennadiy Gurevich; and (ix) Alon Brenner.
    (b)Address or principal business office or, if none, residence:

    256 West 38th Street, 15th Floor, New York 10018.
    (c)Citizenship:

    Each of Dominion GP, Dominion Holdings, Ascent and AP is a Delaware limited liability company. Dominion is a Connecticut limited liability company. Masada is a Florida limited liability company. Each of Mikhail Gurevich, Gennadiy Gurevich, and Alon Brenner is a citizen of the United States.
    (d)Title of class of securities:

    Common Stock, par value $0.0001 per share
    (e)CUSIP No.:

    92919Y102
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    The information required by this item with respect to each Reporting Person is set forth on rows 5 through 9 and 11 of the cover page to this Schedule 13G and is incorporated herein by reference for each such Reporting Person. The ownership percentages reported are based on (i) 16,422,690 shares of Common Stock outstanding as reported by the issuer in its Annual Report, plus 600,000 shares of Common Stock converted by Dominion Capital on September 3, 2025, for a total of 17,022,690 shares outstanding; including an aggregate of 200,000 shares of Common Stock directly held by Ascent and an aggregate of 457,000 shares of Common Stock directly held by Dominion as of September 30, 2025, and (ii) shares of Common Stock issuable upon conversion of certain convertible promissory notes of the issuer (the "Convertible Notes"), the exercise of certain common stock purchase warrants of the issuer (the "Warrants"), as applicable to each Reporting Person, each subject to the Blocker (as defined below). As of September 30, 2025, Dominion and Ascent each directly hold certain of the Convertible Notes, as applicable, which are currently convertible into an aggregate of 1,626,022 and 1,111,112, respectively, shares of Common Stock, which are in each case, subject to a 9.99% beneficial ownership limitation provision contained therein (a "Blocker"). As of September 30, 2025, Dominion and Ascent each directly hold the Warrants, which are exercisable to purchase an aggregate of 173,913 and 740,741, respectively, shares of Common Stock, which are in each case, subject to a Blocker. The percentage set forth on row (11) and the number of shares of Common Stock set forth on rows (6), (8) and (9) of the cover page for each Reporting Person give effect to the Blockers in the Convertible Notes and the Warrants. Each of Mikhail Gurevich and Gennadiy Gurevich manages Dominion Holdings, Dominion GP, Dominion Capital, AP and Ascent. Dominion Holdings manages Dominion Capital, Dominion GP, AP and Ascent. Dominion GP manages Dominion Capital, AP and Ascent. Dominion Capital manages AP and Ascent. Alon Brenner manages Masada, AP and Ascent. Masada manages AP and Ascent. AP manages Ascent. Ascent has the power to dispose of and the power to vote the shares of Common Stock beneficially owned by it. Each of Mikhail Gurevich, Gennadiy Gurevich, Dominion Holdings, Dominion GP, Dominion Capital, Masada, Alon Brenner and AP may be deemed to beneficially own, and have the power to vote, the shares of Common Stock beneficially owned by Ascent and the other companies they are listed above as managing. On September 30, 2025, Dominion Capital and Ascent each sent a notice under each of their respective Warrants and Convertible Notes to increase the applicable Blocker provision in each such Warrant and Convertible Note to 9.99% (combined across all agreements), which notice was acknowledged by the issuer and shall be effective on the 61st day thereafter.
    (b)Percent of class:

    9.99%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    (A) Dominion: 0.00 (B) Dominion GP: 0.00 (C) Dominion Holdings: 0.00 (D) Ascent: 0.00 (E) AP: 0.00 (F) Masada: 0.00 (G) Mikhail Gurevich: 0.00 (H) Gennadiy Gurevich: 0.00 (I) Alon Brenner: 0.00

     (ii) Shared power to vote or to direct the vote:

    (A) Dominion: 1,816,389.00 (B) Dominion GP: 1,816,389.00 (C) Dominion Holdings: 1,816,389.00 (D) Ascent: 1,816,389.00 (E) AP: 1,816,389.00 (F) Masada: 1,816,389.00 (G) Mikhail Gurevich: 1,816,389.00 (H) Gennadiy Gurevich: 1,816,389.00 (I) Alon Brenner: 1,816,389.00

     (iii) Sole power to dispose or to direct the disposition of:

    (A) Dominion: 0.00 (B) Dominion GP: 0.00 (C) Dominion Holdings: 0.00 (D) Ascent: 0.00 (E) AP: 0.00 (F) Masada: 0.00 (G) Mikhail Gurevich: 0.00 (H) Gennadiy Gurevich: 0.00 (I) Alon Brenner: 0.00

     (iv) Shared power to dispose or to direct the disposition of:

    (A) Dominion: 1,816,389.00 (B) Dominion GP: 1,816,389.00 (C) Dominion Holdings: 1,816,389.00 (D) Ascent: 1,816,389.00 (E) AP: 1,816,389.00 (F) Masada: 1,816,389.00 (G) Mikhail Gurevich: 1,816,389.00 (H) Gennadiy Gurevich: 1,816,389.00 (I) Alon Brenner: 1,816,389.00

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Dominion Capital LLC
     
    Signature:/s/ Dominion Capital LLC
    Name/Title:Mikhail Gurevich, Managing Member of Dominion Holdings, Manager of Dominion GP, Manager of Dominion
    Date:10/01/2025
     
    Dominion Capital GP LLC
     
    Signature:/s/ Dominion Capital GP LLC
    Name/Title:Mikhail Gurevich, Managing Member of Dominion Holdings, Manager of Dominion GP
    Date:10/01/2025
     
    Dominion Capital Holdings LLC
     
    Signature:/s/ Dominion Capital Holdings LLC
    Name/Title:Mikhail Gurevich, Managing Member
    Date:10/01/2025
     
    Ascent Partners Fund LLC
     
    Signature:/s/ Ascent Partners Fund LLC
    Name/Title:Mikhail Gurevich, signatory for Dominion, Managing Member of AP, Managing Member of Ascent
    Date:10/01/2025
     
    Ascent Partners LLC
     
    Signature:/s/ Ascent Partners LLC
    Name/Title:Mikhail Gurevich, signatory for Dominion, Managing Member of AP
    Date:10/01/2025
     
    Masada Group Holdings LLC
     
    Signature:/s/ Masada Group Holdings LLC
    Name/Title:Alon Brenner, Managing Member
    Date:10/01/2025
     
    Mikhail Gurevich
     
    Signature:/s/ Mikhail Gurevich
    Name/Title:Mikhail Gurevich
    Date:10/01/2025
     
    Gennadiy Gurevich
     
    Signature:/s/ Gennadiy Gurevich
    Name/Title:Gennadiy Gurevich
    Date:10/01/2025
     
    Alon Brenner
     
    Signature:/s/ Alon Brenner
    Name/Title:Alon Brenner
    Date:10/01/2025
    Get the next $VSEE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSEE

    DatePrice TargetRatingAnalyst
    2/24/2025$5.00Buy
    Maxim Group
    More analyst ratings

    $VSEE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on VSee Lab with a new price target

    Maxim Group initiated coverage of VSee Lab with a rating of Buy and set a new price target of $5.00

    2/24/25 8:42:03 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-CEO Aisiku Imoigele disposed of 120,000 shares, decreasing direct ownership by 3% to 3,416,990 units (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    11/19/24 8:57:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Large owner Sands Lawrence M. acquired $405,000 worth of shares (202,500 units at $2.00) (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    11/19/24 8:55:08 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Large owner Sands Lawrence M. acquired 2,500 shares (SEC Form 4)

    4 - VSEE HEALTH, INC. (0001864531) (Issuer)

    8/26/24 6:00:12 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite. VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee's AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician's charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity. This new VSee AI solution automatically transcribes visits and generates

    7/14/25 8:17:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

    VSee Health, Inc. (NASDAQ:VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions. The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke re

    6/23/25 8:27:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

    VSee Health, Inc. (the "Company") (NASDAQ:VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Nasdaq notice has no immediate effect on the listing or trading of the Company's common stock or its public warrants on The Nasdaq Capital Market.

    5/30/25 4:07:00 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by VSee Health Inc.

    SCHEDULE 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    10/1/25 5:26:12 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form 8-K filed by VSee Health Inc.

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    9/26/25 8:19:37 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form 8-K filed by VSee Health Inc.

    8-K - VSEE HEALTH, INC. (0001864531) (Filer)

    9/5/25 5:20:40 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    $VSEE
    Financials

    Live finance-specific insights

    View All

    VSee Health Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 20, 2024 / RedChip Companies will air an interview with VSee Health, Inc. (NASDAQ:VSEE) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, December 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interview in its entirety at: https://www.redchip.com/assets/access/vsee_accessIn an exclusive interview, Milton Chen, PhD, co-CEO of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated solutions position the company as a growing leader in the $787 billion telehealth

    12/20/24 9:00:00 AM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (NASDAQ:VSEE) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:VSEE: https://www.redchip.com/assets/access/vsee_accessSXTP: https://www.redchip.com/assets/access/sxtp_accessIn an exclusive interview, Imo Aisiku, M.D., co-CEO and Chairman of VSee Health, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share insight into how VSee Health's differentiated so

    12/2/24 4:05:00 PM ET
    $SXTP
    $VSEE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services

    $VSEE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 8:45:14 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by VSee Health Inc.

    SC 13G/A - VSEE HEALTH, INC. (0001864531) (Subject)

    11/14/24 5:23:34 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by VSee Health Inc.

    SC 13G - VSEE HEALTH, INC. (0001864531) (Subject)

    7/5/24 4:29:01 PM ET
    $VSEE
    Medical/Nursing Services
    Health Care